Mark A. Gohr
Finanzdirektor/CFO bei ANTH1, Inc.
Profil
Mark A.
Gohr is currently the Chief Financial & Accounting Officer at ANTH1, Inc. He completed his undergraduate degree at Hastings College and his graduate degree at The University of Colorado.
Aktive Positionen von Mark A. Gohr
| Unternehmen | Position | Beginn |
|---|---|---|
ANTH1, Inc.
 ANTH1, Inc. Pharmaceuticals: MajorHealth Technology ANTH1, Inc. operates as a development stage company. It is a biotechnology company dedicated to developing vaccines for several infectious diseases including H5N1 influenza virus. The firm utilizes state of the art recombinant DNA adenoviral vector and Rnai (inhibition RNA) technologies to develop highly specific genetic vaccines. The company was founded on September 10, 2007 and is headquartered in Conifer, CO. | Finanzdirektor/CFO | 17.06.2010 |
Ausbildung von Mark A. Gohr
| The University of Colorado | Graduate Degree |
| Hastings College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
ANTH1, Inc.
ANTH1, Inc. Pharmaceuticals: MajorHealth Technology ANTH1, Inc. operates as a development stage company. It is a biotechnology company dedicated to developing vaccines for several infectious diseases including H5N1 influenza virus. The firm utilizes state of the art recombinant DNA adenoviral vector and Rnai (inhibition RNA) technologies to develop highly specific genetic vaccines. The company was founded on September 10, 2007 and is headquartered in Conifer, CO. | Health Technology |
